bioAffinity Technologies: HRT Financial reports 10.9% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
bioAffinity Technologies, Inc. (BIAF) common stock was the subject of HRT Financial LP’s beneficial-ownership report. HRT reported 127,132 shares beneficially owned as of September 30, 2026, including 126,146 shares held directly and 986 shares issuable upon exercise of certain warrants. The reported stake was 10.9% of the class, calculated using 1,166,625 shares outstanding as of September 30, 2026, plus the 986 warrant shares, for a denominator of 1,167,611 shares.
Key Figures
Key Terms
beneficially owned regulatory
sole voting power regulatory
sole dispositive power regulatory
warrants financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of BIAF did HRT Financial LP report?
AI-generated analysis. How Rhea-AI works. Not financial advice.